(Reuters) -Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the weight loss achieved with Eli Lilly's ...
(Reuters) -Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight patients lower their weight by 20.7%. The trial was testing ...
November semiconductor sales of $57.8 billion were up 20.7% on the $47.9 billion of November 2023 and up 1.6% on October’s total of $56.9 billion, reports the SIA. November semiconductor sales of ...
Trina Solar claims it has developed the world’s first “fully recyclable” 645 W PV module with 20.7% efficiency. It made the panel with interlayer separation reagents, chemical etching ...